A refill can arrive on a predictable schedule while your circumstances change. You may have started another medicine, developed a symptom, missed a follow-up discussion, or received a vial with a different-looking label. Those changes deserve attention before the next order becomes routine.
Think of a refill as two decisions: whether the clinical plan still makes sense, and whether you want the next financial commitment. A payment reminder does not answer the medical question. A medical appointment does not necessarily stop a pending subscription charge.
Review the treatment plan and the billing deadline as two separate tasks.
Start with the reason for continuing
Before reviewing the price, return to the purpose of treatment. What change were you and the prescriber looking for? What has actually happened? List useful improvements, no change, and anything that has become harder. Include changes in sleep, activity, other treatment, or illness that could affect the picture.
Our results-timeline guide helps distinguish a meaningful outcome from waiting for a marketing milestone. A renewal should not depend only on having reached a certain month or seeing a higher laboratory result. Ask the clinician how the observations affect the next decision.
Report changes before assuming the plan is unchanged
Give the prescriber an updated medication and supplement list, including medicines prescribed elsewhere. Describe new symptoms and when they started. If another clinician has changed your care, make that information available rather than assuming records have already moved between systems.
Use the side-effects guide to organize a symptom message. Customer service may handle delivery and billing, but the clinical team should address whether a symptom or new treatment affects the prescription. Do not wait for an ordinary renewal response when symptoms require urgent medical attention.
Read the new label as a new label
Compare the pharmacy name, ingredients, concentration, prescribed directions, and beyond-use information with the instructions you were given. A changed container or concentration can make a familiar-looking syringe routine unsafe to assume. Ask the pharmacy to resolve any discrepancy before using the new supply.
The dosage and units guide explains why milligrams, milliliters, and syringe markings are different measurements. This checklist does not provide a conversion. Keep the current label and written instructions together so the prescriber and pharmacist can review the same information.
Close the loop on any testing
If testing was ordered, check whether the result has been received and explained. Ask whether it changes the treatment decision or simply supplies one piece of a broader assessment. A portal notification that a value is within a range is not the same as a clinical review of the whole plan.
Read IGF-1 and blood tests for background. Do not order a universal panel from a refill checklist or adjust a prescription to chase a number. Agree on who reviews the results and how you will hear back before the next decision point.
Put the processing date on the calendar
Ask when the next payment is taken, when the prescription reaches the pharmacy, and when cancellation becomes too late to reverse that order. These can be different dates. Save any cancellation confirmation and ask explicitly whether it affects a pending fill as well as future renewals.
The AgelessRx review and Brightmeds review show why broad cancellation headlines need closer reading. If care is paused or changed, ask the clinician what to do with the remaining medicine and the pharmacy about its storage or disposal. This is not a schedule for stopping, restarting, or tapering treatment yourself.
Follow the sources.
Provider pages establish advertised terms, not independently measured outcomes. General medical guidance does not validate every compounded preparation.
- FDA: Managing the benefits and risks of medicines (opens in a new tab)
General questions for evaluating benefit, follow-up and new medicines.
- Endocrine Society: Hormones and aging statement overview (opens in a new tab)
Checked September 23, 2026. Distinguishes normal aging from disease and identifies the lack of an approved GH anti-aging intervention.
- Mayo Clinic: Sermorelin injection information (opens in a new tab)
Rechecked September 23, 2026. Historical branded injection information; not the label for a present-day compounded preparation or evidence of adult anti-aging benefit.
- FDA: Compounding questions and answers (opens in a new tab)
Compounded medicines differ from FDA-approved generic drugs.
- FDA: Compounded injectable semaglutide measurement errors (opens in a new tab)
Checked September 23, 2026. This alert concerns semaglutide, not sermorelin. Used only to explain why concentration and measurement instructions require verification.
- MedlinePlus: IGF-1 blood testing (opens in a new tab)
Checked September 23, 2026. Explains laboratory purpose and limitations. A low result alone does not identify a treatment.
- Endocrine Society: Adult growth hormone deficiency (opens in a new tab)
Diagnosis and treatment of established deficiency; not an endorsement of anti-aging prescribing.
- AgelessRx: Orders and cancellation FAQ (opens in a new tab)
Checked September 23, 2026 through web retrieval. Distinguish pausing future orders from refunds after pharmacy processing or dispatch.
- AgelessRx: Terms and conditions (opens in a new tab)
Checked September 23, 2026 through web retrieval. Subscription processing deadlines and cash-pay terms differ from a general pause-anytime headline.
- Brightmeds: Linked refund and cancellation policy (opens in a new tab)
Checked September 23, 2026. Shared policy opens by describing GLP-1 subscriptions. Confirm its deadlines and exclusions for a sermorelin order.
